Dec 11, 2020 Notizie
[Biomedicines IF 4.717]
Paper Invitation on "Obesity and Diabetes: Impact on Cancer"
I am Vittoria D'Esposito and work at the Institute of Experimental Endocrinology and Oncology (IEOS) of the National Research Council (CNR), Naples, Italy.
As the guest editor, I sincerely invite you to contribute a full research paper or review article for peer-review and possible publication in Biomedicines special issue "Obesity and Diabetes: Impact on Cancer".
https://www.mdpi.com/journal/biomedicines/special_issues/Obesity_Diabetes_Cancer Authors are invited to contribute original articles or comprehensive reviews in this field. All submissions are peer-reviewed, and accepted papers will be published online shortly. A 200 CHF discount for papers invited by the guest editors will be offered.
*Benefits* of publishing with Biomedicines:
1. Open access. Open access (unlimited and free access to readers) increases publicity and promotes more frequent citations, as indicated by several studies.
2. High visibility and impact. Biomedicines is indexed by the leading indexing services, like PubMed, Scopus and SCIE.
3. Rapid publication times combined with thorough peer review. A first decision is provided to authors approximately 13.9 days after submission; acceptance to publication is typically undertaken in days.
4. Discounts on Article Processing Charges (APC). An Article Processing Charge (APC) of 1400 CHF currently applies to all accepted papers in 2020, please note that for papers submitted after 31 December 2020 an APC of 2000 CHF applies. You may be entitled to a discount if you have previously received a discount code (as a peer reviewer).
If you are interested, please, send a tentative title or/and short abstract to me or Biomedicines assistant editor linsa (firstname.lastname@example.org) in advance. Please feel free to contact us if you have any questions.
For further details on the submission process, please see the Instructions for Authors at http://www.mdpi.com/journal/biomedicines/instructions.
I look forward to hearing from you.